Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study

Monoamine oxidases (MAOs) catalyze the degradation of a very broad range of biogenic and dietary amines including many neurotransmitters in the brain, whose imbalance is extensively linked with the biochemical pathology of various neurological disorders, and are, accordingly, used as primary pharmac...

Full description

Bibliographic Details
Main Authors: Tana Tandarić, Alja Prah, Jernej Stare, Janez Mavri, Robert Vianello
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/17/6151
_version_ 1797555460755161088
author Tana Tandarić
Alja Prah
Jernej Stare
Janez Mavri
Robert Vianello
author_facet Tana Tandarić
Alja Prah
Jernej Stare
Janez Mavri
Robert Vianello
author_sort Tana Tandarić
collection DOAJ
description Monoamine oxidases (MAOs) catalyze the degradation of a very broad range of biogenic and dietary amines including many neurotransmitters in the brain, whose imbalance is extensively linked with the biochemical pathology of various neurological disorders, and are, accordingly, used as primary pharmacological targets to treat these debilitating cognitive diseases. Still, despite this practical significance, the precise molecular mechanism underlying the irreversible MAO inhibition with clinically used propargylamine inhibitors rasagiline and selegiline is still not unambiguously determined, which hinders the rational design of improved inhibitors devoid of side effects current drugs are experiencing. To address this challenge, we present empirical valence bond QM/MM simulations of the rate-limiting step of the MAO inhibition involving the hydride anion transfer from the inhibitor α-carbon onto the N5 atom of the flavin adenin dinucleotide (FAD) cofactor. The proposed mechanism is strongly supported by the obtained free energy profiles, which confirm a higher reactivity of selegiline over rasagiline, while the calculated difference in the activation Gibbs energies of ΔΔ<b><i>G</i></b><sup>‡</sup> = 3.1 kcal mol<sup>−1</sup> is found to be in very good agreement with that from the measured literature <b><i>k</i></b><sub>inact</sub> values that predict a 1.7 kcal mol<sup>−1</sup> higher selegiline reactivity. Given the similarity with the hydride transfer mechanism during the MAO catalytic activity, these results verify that both rasagiline and selegiline are mechanism-based irreversible inhibitors and offer guidelines in designing new and improved inhibitors, which are all clinically employed in treating a variety of neuropsychiatric and neurodegenerative conditions.
first_indexed 2024-03-10T16:48:46Z
format Article
id doaj.art-693acc386959409b81e2ec7c7e0e89be
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T16:48:46Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-693acc386959409b81e2ec7c7e0e89be2023-11-20T11:25:15ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-08-012117615110.3390/ijms21176151Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond StudyTana Tandarić0Alja Prah1Jernej Stare2Janez Mavri3Robert Vianello4Division of Organic Chemistry and Biochemistry, Ruđer Bošković Institute, Bijenička Cesta 54, HR-10000 Zagreb, CroatiaLaboratory for Computational Biochemistry and Drug Design, National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, SloveniaLaboratory for Computational Biochemistry and Drug Design, National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, SloveniaLaboratory for Computational Biochemistry and Drug Design, National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, SloveniaDivision of Organic Chemistry and Biochemistry, Ruđer Bošković Institute, Bijenička Cesta 54, HR-10000 Zagreb, CroatiaMonoamine oxidases (MAOs) catalyze the degradation of a very broad range of biogenic and dietary amines including many neurotransmitters in the brain, whose imbalance is extensively linked with the biochemical pathology of various neurological disorders, and are, accordingly, used as primary pharmacological targets to treat these debilitating cognitive diseases. Still, despite this practical significance, the precise molecular mechanism underlying the irreversible MAO inhibition with clinically used propargylamine inhibitors rasagiline and selegiline is still not unambiguously determined, which hinders the rational design of improved inhibitors devoid of side effects current drugs are experiencing. To address this challenge, we present empirical valence bond QM/MM simulations of the rate-limiting step of the MAO inhibition involving the hydride anion transfer from the inhibitor α-carbon onto the N5 atom of the flavin adenin dinucleotide (FAD) cofactor. The proposed mechanism is strongly supported by the obtained free energy profiles, which confirm a higher reactivity of selegiline over rasagiline, while the calculated difference in the activation Gibbs energies of ΔΔ<b><i>G</i></b><sup>‡</sup> = 3.1 kcal mol<sup>−1</sup> is found to be in very good agreement with that from the measured literature <b><i>k</i></b><sub>inact</sub> values that predict a 1.7 kcal mol<sup>−1</sup> higher selegiline reactivity. Given the similarity with the hydride transfer mechanism during the MAO catalytic activity, these results verify that both rasagiline and selegiline are mechanism-based irreversible inhibitors and offer guidelines in designing new and improved inhibitors, which are all clinically employed in treating a variety of neuropsychiatric and neurodegenerative conditions.https://www.mdpi.com/1422-0067/21/17/6151irreversible inhibitionmonoamine oxidasehydride transferantiparkinsonian drugsneurodegenerationflavoenzymes
spellingShingle Tana Tandarić
Alja Prah
Jernej Stare
Janez Mavri
Robert Vianello
Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
International Journal of Molecular Sciences
irreversible inhibition
monoamine oxidase
hydride transfer
antiparkinsonian drugs
neurodegeneration
flavoenzymes
title Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
title_full Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
title_fullStr Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
title_full_unstemmed Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
title_short Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
title_sort hydride abstraction as the rate limiting step of the irreversible inhibition of monoamine oxidase b by rasagiline and selegiline a computational empirical valence bond study
topic irreversible inhibition
monoamine oxidase
hydride transfer
antiparkinsonian drugs
neurodegeneration
flavoenzymes
url https://www.mdpi.com/1422-0067/21/17/6151
work_keys_str_mv AT tanatandaric hydrideabstractionastheratelimitingstepoftheirreversibleinhibitionofmonoamineoxidasebbyrasagilineandselegilineacomputationalempiricalvalencebondstudy
AT aljaprah hydrideabstractionastheratelimitingstepoftheirreversibleinhibitionofmonoamineoxidasebbyrasagilineandselegilineacomputationalempiricalvalencebondstudy
AT jernejstare hydrideabstractionastheratelimitingstepoftheirreversibleinhibitionofmonoamineoxidasebbyrasagilineandselegilineacomputationalempiricalvalencebondstudy
AT janezmavri hydrideabstractionastheratelimitingstepoftheirreversibleinhibitionofmonoamineoxidasebbyrasagilineandselegilineacomputationalempiricalvalencebondstudy
AT robertvianello hydrideabstractionastheratelimitingstepoftheirreversibleinhibitionofmonoamineoxidasebbyrasagilineandselegilineacomputationalempiricalvalencebondstudy